Sugar Maple Asset Management’s Transmedics TMDX Stock Holding History

Sugar Maple Asset Management’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$399K	Buy	6,000 +3,000	+100%	+$254K	0.26%	59
2026 Q1	$298K	Hold	3,000	–	–	0.18%	71
2025 Q4	$365K	Hold	3,000	–	–	0.25%	61
2025 Q3	$337K	Sell	3,000 -1,000	-25%	-$117K	0.24%	63
2025 Q2	$536K	Sell	4,000 -7,000	-64%	-$769K	0.42%	41
2025 Q1	$740K	Buy	+11,000	New	+$757K	0.58%	33

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Sugar Maple Asset Management's TMDX Position: Q2 2026 in Review

Sugar Maple Asset Management increased its Transmedics (TMDX) stake by 100% in Q2 2026, buying an estimated $254K and bringing the position to 6,000 shares worth $399K. The position accounts for 0.26% of the portfolio, ranked #59.

Sugar Maple Asset Management first reported a position in TMDX in Q1 2025 and has held it in 6 quarters since. The position peaked at $740K in Q1 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

Sugar Maple Asset Management held 6,000 shares of Transmedics worth $399K as of Q2 2026.
Sugar Maple Asset Management bought 3,000 Transmedics shares in Q2 2026, an estimated $254K.
Transmedics made up 0.26% of Sugar Maple Asset Management's portfolio in Q2 2026, its #59 holding.
Sugar Maple Asset Management first reported a position in Transmedics in Q1 2025 and has held it in 6 quarters since.
Sugar Maple Asset Management's Transmedics position peaked at $740K in Q1 2025.
375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Sugar Maple Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.